Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26 save search
Updated Results from the Phase 1/2 Study of ESSA's Lead Candidate EPI-7386 in Combination with Enzalutamide Highlighted at the 29th Annual Prostate Cancer Foundation Scientific Retreat
Published: 2022-10-26 (Crawled : 14:00) - biospace.com/
EPIX | $7.01 -0.85% 11K
|
Health Technology
|
| O: 19.19%
H: 148.78%
C: 135.12%
epi-7386 candidate results cancer study prostate cancer phase 1
ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
EPIX | $7.01 -0.85% 11K
|
Health Technology
|
| O: 19.19%
H: 148.78%
C: 135.12%
pharma preclinical symposium
Freight Technologies, Inc. Expands Relationship with Leading Glass Container Manufacturer to Incorporate Canadian Routes
Published: 2022-10-26 (Crawled : 15:00) - globenewswire.com
FRGT | News | $0.9306 23K
|
n/a
|
| O: 9.3%
H: 82.98%
C: 25.74%
glass
GreenPower's BEAST and Nano BEAST All-Electric School Buses Eligible for Purchase Under Today's EPA Announcement
Published: 2022-10-26 (Crawled : 13:00) - prnewswire.com
GP | $1.75 2.84% 98K
|
Consumer Durables
|
| O: 1.46%
H: 38.94%
C: 21.63%
announcement
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. Extend Their Stay of Pending Litigation to Provide Additional Time for The Parties to Finalize Their Settlement
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -13.46%
H: 28.44%
C: 20.0%
therapeutics
mCloud Announces Proposed Unsecured Loan from Strategic Investors
Published: 2022-10-26 (Crawled : 23:00) - prnewswire.com
MCLD | $0.111 -18.02% 1.1M
|
n/a
|
| O: 11.46%
H: 50.48%
C: 18.1%
New Oriental Announces Results for the First Fiscal Quarter Ended August 31, 2022
Published: 2022-10-26 (Crawled : 11:00) - prnewswire.com
EDU | $86.61 2.44% 620K
|
Consumer Services
|
| O: 9.45%
H: 21.04%
C: 17.22%
NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
NBY | News | $0.0815 -1.69% 2.7M
|
Health Technology
|
| O: -3.05%
H: 26.38%
C: 15.42%
pharmaceuticals expansion
4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
Published: 2022-10-26 (Crawled : 21:00) - globenewswire.com
FDMT | $25.065 -0.93% 140K
|
Health Technology
|
| O: 1.17%
H: 34.79%
C: 14.63%
fibrosis lung disease trial therapeutics molecular cystic fibrosis
Vaxcyte Announces Pricing of $600 Million Public Offering
Published: 2022-10-26 (Crawled : 05:00) - globenewswire.com
PCVX | $61.26 -1.87% 120K
|
Health Technology
|
| O: 2.12%
H: 18.76%
C: 14.61%
STRO M | $3.705 -2.5% 200K
|
Health Technology
|
| O: 0.43%
H: 3.37%
C: 2.44%
offering
ADIPEC 2022
Published: 2022-10-26 (Crawled : 14:00) - nabors.com
NETC | $11.0 21.73% 2.9K
|
n/a
|
| O: 0.2%
H: 0.0%
C: -0.1%
NBR | $76.2 1.47% 77K
|
Industrial Services
|
| O: 8.63%
H: 17.22%
C: 12.67%
Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: 2.22%
H: 8.7%
C: 8.7%
MCRB | $0.5992 -4.48% 2.4M
|
Health Technology
|
| O: 1.39%
H: 16.24%
C: 12.65%
ser-109 fda application license therapeutics review infection
Clever Leaves to Hold Third Quarter 2022 Conference Call on Wednesday, November 9, 2022 at 5:00 p.m. ET
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
CLVR | $4.23 4.1K
|
|
| O: -3.56%
H: 13.26%
C: 11.47%
conference
Garrett Motion Reports Third Quarter 2022 Financial Results
Published: 2022-10-26 (Crawled : 11:00) - globenewswire.com
GTX | $9.195 0.6% 170K
|
Manufacturing
|
| O: -0.34%
H: 14.43%
C: 11.34%
financial results
Propanc Biopharma’s CEO to Present at Sidoti & Company Micro-Cap Virtual Investor Conference
Published: 2022-10-26 (Crawled : 18:00) - biospace.com/
PPCB | $0.0014 4.4M
|
Manufacturing
|
| O: 0.0%
H: 11.11%
C: 11.11%
ceo conference
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Published: 2022-10-26 (Crawled : 13:00) - globenewswire.com
CWBR | $0.9003 360
|
Health Technology
|
| O: -1.78%
H: 17.65%
C: 10.86%
financial update results
PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform
Published: 2022-10-26 (Crawled : 03:00) - prnewswire.com
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -2.92%
H: 12.39%
C: 10.39%
platform
PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15
Published: 2022-10-26 (Crawled : 03:00) - prnewswire.com
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -2.92%
H: 12.39%
C: 10.39%
day report
PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000
Published: 2022-10-26 (Crawled : 04:00) - prnewswire.com
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -2.92%
H: 12.39%
C: 10.39%
system
PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15, 2022
Published: 2022-10-26 (Crawled : 08:00) - biospace.com/
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -2.92%
H: 12.39%
C: 10.39%
day report
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.